Literature DB >> 26224809

A Not-So-Little Role for Lipoprotein(a) in the Development of Calcific Aortic Valve Disease.

Maximillian A Rogers1, Elena Aikawa2.   

Abstract

Entities:  

Keywords:  Editorials; PCSK9 protein, human; heart valves; vascular calcification

Mesh：

Substances：

Year:  2015        PMID： 26224809      PMCID： PMC4550561          DOI： 10.1161/CIRCULATIONAHA.115.018139

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

Review 1.  NPP-type ectophosphodiesterases: unity in diversity.

Authors:  Cristiana Stefan; Silvia Jansen; Mathieu Bollen
Journal:  Trends Biochem Sci       Date:  2005-10       Impact factor: 13.807

Review 2.  Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.

Authors:  Rosario V Freeman; Catherine M Otto
Journal:  Circulation       Date:  2005-06-21       Impact factor: 29.690

3.  HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

Authors:  G M Kostner; D Gavish; B Leopold; K Bolzano; M S Weintraub; J L Breslow
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

4.  Bone defects in LPA receptor genetically modified mice.

Authors:  Jean Pierre Salles; Sara Laurencin-Dalicieux; Françoise Conte-Auriol; Fabienne Briand-Mésange; Isabelle Gennero
Journal:  Biochim Biophys Acta       Date:  2012-07-31

Review 5.  Insights into autotaxin: how to produce and present a lipid mediator.

Authors:  Wouter H Moolenaar; Anastassis Perrakis
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-14       Impact factor: 94.444

6.  Lipoprotein[a] as a risk factor for preclinical atherosclerosis.

Authors:  P J Schreiner; J D Morrisett; A R Sharrett; W Patsch; H A Tyroler; K Wu; G Heiss
Journal:  Arterioscler Thromb       Date:  1993-06

7.  Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.

Authors:  Akira Tokumura; Eiji Majima; Yuko Kariya; Kyoko Tominaga; Kentaro Kogure; Katsuhiko Yasuda; Kenji Fukuzawa
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

8.  Scavenger receptor-BI is a receptor for lipoprotein(a).

Authors:  Xiao-Ping Yang; Marcelo J Amar; Boris Vaisman; Alexander V Bocharov; Tatyana G Vishnyakova; Lita A Freeman; Roger J Kurlander; Amy P Patterson; Lewis C Becker; Alan T Remaley
Journal:  J Lipid Res       Date:  2013-06-29       Impact factor: 5.922

9.  The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site.

Authors:  Rik Gijsbers; Junken Aoki; Hiroyuki Arai; Mathieu Bollen
Journal:  FEBS Lett       Date:  2003-03-13       Impact factor: 4.124

10.  Genetic associations with valvular calcification and aortic stenosis.

Authors:  George Thanassoulis; Catherine Y Campbell; David S Owens; J Gustav Smith; Albert V Smith; Gina M Peloso; Kathleen F Kerr; Sonali Pechlivanis; Matthew J Budoff; Tamara B Harris; Rajeev Malhotra; Kevin D O'Brien; Pia R Kamstrup; Børge G Nordestgaard; Anne Tybjaerg-Hansen; Matthew A Allison; Thor Aspelund; Michael H Criqui; Susan R Heckbert; Shih-Jen Hwang; Yongmei Liu; Marketa Sjogren; Jesper van der Pals; Hagen Kälsch; Thomas W Mühleisen; Markus M Nöthen; L Adrienne Cupples; Muriel Caslake; Emanuele Di Angelantonio; John Danesh; Jerome I Rotter; Sigurdur Sigurdsson; Quenna Wong; Raimund Erbel; Sekar Kathiresan; Olle Melander; Vilmundur Gudnason; Christopher J O'Donnell; Wendy S Post
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245
View more
  6 in total

1.  Creation of disease-inspired biomaterial environments to mimic pathological events in early calcific aortic valve disease.

Authors:  Ana M Porras; Jennifer A Westlund; Austin D Evans; Kristyn S Masters
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-27       Impact factor: 11.205

Review 2.  Calcific aortic stenosis.

Authors:  Brian R Lindman; Marie-Annick Clavel; Patrick Mathieu; Bernard Iung; Patrizio Lancellotti; Catherine M Otto; Philippe Pibarot
Journal:  Nat Rev Dis Primers       Date:  2016-03-03       Impact factor: 52.329

3.  Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets.

Authors:  Alexia Hulin; Alexandre Hego; Patrizio Lancellotti; Cécile Oury
Journal:  Front Cardiovasc Med       Date:  2018-03-14

Review 4.  Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction.

Authors:  Enas A Enas; Basil Varkey; T S Dharmarajan; Guillaume Pare; Vinay K Bahl
Journal:  Indian Heart J       Date:  2019-03-20

Review 5.  Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease.

Authors:  Hayato Tada; Masayuki Takamura; Masa-Aki Kawashiri
Journal:  J Atheroscler Thromb       Date:  2019-04-30       Impact factor: 4.928

6.  Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in aortic stenosis - Is this the light at the end of the tunnel for patients with aortic stenosis?

Authors:  Sourabh Agstam; Tushar Agarwal; Anunay Gupta; Sandeep Bansal
Journal:  Indian Heart J       Date:  2021-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.